No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Equinoxe Humeral Augmented Tray: 1st Shoulder Surgeries with New Solution for Proximal Humeral Bone Loss Performed in Florida

Editor: What To Know

  • The first surgeries with the Humeral Augmented Tray were performed last week in Florida by Bradley Schoch, MD, of the Mayo Clinic in Jacksonville, and design team surgeon Howard Routman, DO, of JFK Medical Center in Lantana.
  • “This implant allows them to return to what they love, and I feel very honored to have been part of the design team and one of the first to use this prosthesis.
  • The HAT was designed to be used in combination with the Equinoxe Platform Shoulder System for reverse procedures and was designed to help improve joint mechanics and stability for patients with proximal humeral bone loss.

March 29, 2021

The Equinoxe Humeral Augmented Tray is the first implant of its kind. It replaces the greater tuberosity, a part of the shoulder that may be absent or deficient, fractured and/or reabsorbed due to disease.

The HAT was designed to be used in combination with the Equinoxe Platform Shoulder System for reverse procedures and was designed to help improve joint mechanics and stability for patients with proximal humeral bone loss. This unique implant can also be used with an extension for more severe proximal bone loss cases.

The first surgeries with the Humeral Augmented Tray were performed last week in Florida by Bradley Schoch, MD, of the Mayo Clinic in Jacksonville, and design team surgeon Howard Routman, DO, of JFK Medical Center in Lantana.

“The patients who need this implant have either previously undergone surgeries which failed, suffered fractures of the humeral head, or have congenital abnormalities that leave them with deficient tuberosities, which prevent them from doing what they want,” said Dr. Routman. “This implant allows them to return to what they love, and I feel very honored to have been part of the design team and one of the first to use this prosthesis.”

“We are very pleased to launch the Humeral Augmented Tray and excited to receive feedback from our surgeon colleagues and see its impact on patients. Its addition to the Equinoxe Shoulder family allows us to reach even more patients,” said Vice President of Extremities Chris Roche.

The design team includes Dr. Routman, Thomas Wright, MD, of the University of Florida in Gainesville, Fla.; Pierre-Henri Flurin, MD, of Surgical Clinic of Bordeaux in Merginac, France; Matthew Hansen, MD, of Banner Gateway Medical Center in Gilbert, Ariz.; Raymond Klug, MD, of Lakewood Regional Medical Center in Lakewood, Calif.; and Joseph D. Zuckerman, MD, of NYU Langone Orthopedic Hospital in New York City.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy